PAdd image
Pinealon
CognitiveSingleA Khavinson-family bioregulator targeting the pineal gland, studied for cognitive function, sleep, and circadian regulation.
Half-life
—
Common dose
10 – 20 mg
Dosing frequency
Daily
Administration
Subcutaneous
How it works
Pinealon is theorized to act as a peptide bioregulator that influences pineal cell gene expression, supporting melatonin synthesis pathways and circadian regulation.
Protocol notes
Typical protocols use 10–20 mg subcutaneously daily for 10–20 day courses, repeated 2–3 times per year.
Reported side effects
Reported as well-tolerated in Russian research. Limited Western data.